Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Source 65

List of Tables
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region, 2018* 7
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 13
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 15
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 18
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 13
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 15
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Polypoidal Choroidal Vasculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Polypoidal Choroidal Vasculopathy to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 18
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Polypoidal Choroidal Vasculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Polypoidal Choroidal Vasculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Polypoidal Choroidal Vasculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Polypoidal Choroidal Vasculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 64

Companies Mentioned
- Bayer AG
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc
- Chengdu Kanghong Pharmaceuticals Group Co Ltd
- Ophthotech Corp
- Mateon Therapeutics Inc
- Laboratory Corp of America Holdings
- Cabyc SL
- Apollo Endosurgery Inc